Company intelligence / Profile preview

Concorde

Ahmedabad, Gujarat, Indiaconcordesst.com ↗

Ownership: Private
Employees: ~1180
Development stage: Other

Overview

Leading Indian biotech specializing in fermentation-based APIs & formulations across immunology/onco/infectious disease with global reach (>70 countries). First Indian co. to develop tacrolimus via fermentation route.

Therapeutic areas: OncologyImmunologyOtherNeurologyNephrologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Partnerships with global pharmaceutical companies

Beyond the preview

Go deeper on Concorde.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concorde.

Explore the full profile